# ETNK2

## Overview
ETNK2, or ethanolamine kinase 2, is a gene that encodes a protein belonging to the kinase family, specifically involved in the phosphorylation of ethanolamine. This enzyme plays a pivotal role in the CDP-ethanolamine pathway, also known as the Kennedy pathway, which is crucial for the biosynthesis of phosphatidylethanolamine (PE), a key phospholipid component of cellular membranes. The protein ethanolamine kinase 2 catalyzes the conversion of ethanolamine to phosphoethanolamine, a critical step in maintaining the structural integrity and function of cellular membranes, particularly in tissues with high electrical activity such as the brain, skeletal muscle, and heart (St2023Phosphatidylethanolamine). Variations in the ETNK2 gene can lead to metabolic and neurological disorders, highlighting its importance in cellular homeostasis and human health.

## Function
ETNK2 (ethanolamine kinase 2) is an enzyme that plays a critical role in the CDP-ethanolamine (CDP-Etn) pathway, also known as the Kennedy pathway, which is essential for the synthesis of phosphatidylethanolamine (PE) in human cells. This pathway involves the phosphorylation of ethanolamine to phosphoethanolamine, a reaction catalyzed by ETNK2, using ATP as a phosphate donor (St2023Phosphatidylethanolamine). The CDP-Etn pathway is crucial for maintaining PE homeostasis, which is vital for the structural integrity of cellular membranes, particularly in the inner leaflet of the plasma and mitochondrial membranes (St2023Phosphatidylethanolamine).

PE is a significant component of cell membranes and is involved in various cellular processes, including membrane vesicle formation and neurotransmitter homeostasis. It is particularly important in tissues with high electrical activity, such as the brain, skeletal muscle, and heart (St2023Phosphatidylethanolamine). The activity of ETNK2, along with ETNK1, is localized in the cytoplasm, where it contributes to the production of PE-plasmalogens, which are important antioxidants (St2023Phosphatidylethanolamine). Variations in the expression and activity of enzymes in this pathway can lead to dysfunctions associated with genetic disorders affecting neuronal function (St2023Phosphatidylethanolamine).

## Clinical Significance
Mutations or altered expression of the ETNK2 gene have been implicated in various metabolic disorders and neurological conditions. ETNK2 is a key enzyme in the phosphatidylethanolamine biosynthesis pathway, which is essential for maintaining cell membrane integrity and function. Disruptions in this pathway can lead to significant cellular dysfunction, contributing to the development of disease.

Research is ongoing to elucidate the full clinical implications of ETNK2 mutations. Alterations in ETNK2 expression may affect the production of phosphatidylethanolamine, potentially leading to metabolic imbalances. These imbalances can manifest in a range of disorders, although specific diseases directly linked to ETNK2 mutations are still under investigation.

Neurological conditions are of particular interest, as phosphatidylethanolamine plays a critical role in the nervous system. Changes in ETNK2 activity could impact neuronal cell membranes, possibly contributing to neurodegenerative diseases or other neurological disorders. Understanding the precise mechanisms by which ETNK2 mutations affect neurological health remains a focus of current research efforts.

## Interactions



## References


[1. (St2023Phosphatidylethanolamine) Michaela St Germain, Roya Iraji, and Marica Bakovic. Phosphatidylethanolamine homeostasis under conditions of impaired cdp-ethanolamine pathway or phosphatidylserine decarboxylation. Frontiers in Nutrition, January 2023. URL: http://dx.doi.org/10.3389/fnut.2022.1094273, doi:10.3389/fnut.2022.1094273. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnut.2022.1094273)